These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7618985)

  • 1. Isoniazid preventive therapy in areas of high isoniazid resistance.
    Sterling TR; Brehm WT; Frieden TR
    Arch Intern Med; 1995 Aug 7-21; 155(15):1622-8. PubMed ID: 7618985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors.
    Colice GL
    Arch Intern Med; 1990 Dec; 150(12):2517-22. PubMed ID: 2244768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis.
    Salpeter SR; Sanders GD; Salpeter EE; Owens DK
    Ann Intern Med; 1997 Dec; 127(12):1051-61. PubMed ID: 9412307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxis.
    Rose DN; Schechter CB; Fahs MC; Silver AL
    Am J Prev Med; 1988; 4(2):102-9. PubMed ID: 3134928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis.
    Jordan TJ; Lewit EM; Montgomery RL; Reichman LB
    JAMA; 1991 Jun; 265(22):2987-91. PubMed ID: 2033771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors.
    Rose DN; Schechter CB; Silver AL
    JAMA; 1986 Nov; 256(19):2709-13. PubMed ID: 3773178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid preventive therapy for tuberculosis. Decision analysis considering ethnicity and gender.
    Jordan TJ; Lewit EM; Reichman LB
    Am Rev Respir Dis; 1991 Dec; 144(6):1357-60. PubMed ID: 1741549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid for the tuberculin reactor: take it or leave it.
    Tsevat J; Taylor WC; Wong JB; Pauker SG
    Am Rev Respir Dis; 1988 Jan; 137(1):215-20. PubMed ID: 3276255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive tuberculin skin tests and isoniazid chemoprophylaxis.
    Pickwell SM
    Nurse Pract; 1984 Apr; 9(4):28, 30-1. PubMed ID: 6328384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should young adults with a positive tuberculin test take isoniazid?
    Taylor WC; Aronson MD; Delbanco TL
    Ann Intern Med; 1981 Jun; 94(6):808-13. PubMed ID: 7235424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underutilization of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older. A prospective analysis.
    Sorresso DJ; Mehta JB; Harvill LM; Bentley S
    Chest; 1995 Sep; 108(3):706-11. PubMed ID: 7656620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Containment of tuberculosis. Preventive therapy with isoniazid, and contact investigation.
    Iseman MD
    Chest; 1979 Dec; 76(6 Suppl):801-4. PubMed ID: 389579
    [No Abstract]   [Full Text] [Related]  

  • 13. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors.
    Comstock GW; Edwards PQ
    Am Rev Respir Dis; 1975 May; 111(5):573-7. PubMed ID: 1130750
    [No Abstract]   [Full Text] [Related]  

  • 15. Acceptance of isoniazid preventive therapy by health care workers after tuberculin skin test conversion.
    Camins BC; Bock N; Watkins DL; Blumberg HM
    JAMA; 1996 Apr; 275(13):1013-5. PubMed ID: 8596233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient management of tuberculosis.
    McColloster P; Neff NE
    Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
    Salpeter SR
    West J Med; 1993 Nov; 159(5):560-4. PubMed ID: 8279152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy.
    Stead WW
    Ann Intern Med; 1995 Jun; 122(12):906-12. PubMed ID: 7755225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive chemotherapy].
    Krebs A
    Z Arztl Fortbild (Jena); 1986; 80(16):677-81. PubMed ID: 3491468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.